The Dexcom G6 continuous glucose monitoring (CGM) system has become a cornerstone of diabetes management for hundreds of thousands of people worldwide. By providing real-time glucose readings every five minutes without the need for routine fingerstick calibrations, it offers unprecedented convenience and insight. However, no medical device is perfect. The accuracy of the Dexcom G6—often quantified by its Mean Absolute Relative Difference (MARD) of approximately 9–10% in clinical studies—can vary depending on a range of physiological, environmental, and operational conditions. Understanding these variables is essential for users who want to trust their sensor data and make informed decisions about insulin dosing, exercise, and diet. This article explores the key factors that can affect Dexcom G6 accuracy and provides authoritative guidance on how to maintain reliable readings in real-world conditions.

Factors That Influence Dexcom G6 Accuracy

Temperature Extremes

The Dexcom G6 sensor is designed to operate within a temperature range of 5°C to 42°C (41°F to 108°F). Exposure to temperatures outside this window can distort the electrochemical reaction that converts interstitial glucose into an electrical signal. In high heat, the sensor may over-report glucose levels; in cold, readings may become falsely low. Users should avoid leaving their sensor in direct sunlight, a hot car, or near a heater. Similarly, cold weather activities like skiing or winter jogging may require additional insulation (e.g., a warm bandage or clothing layer over the sensor). The receiver and transmitter also have temperature limits, so storing the device in extreme conditions before insertion can affect performance.

Physical Activity and Exercise

Intense physical activity introduces several accuracy challenges. Rapid changes in blood glucose can outpace the lag time between blood and interstitial fluid (typically 5–10 minutes). During high-intensity exercise, glucose may be consumed quickly by muscles, but the sensor reading may still reflect pre-exercise levels, creating a temporary discrepancy. Additionally, dehydration, sweating, and pressure from sportswear can all affect the sensor's contact with the skin. The Dexcom G6 is cleared for use during exercise, but users are advised to confirm unusual readings with a fingerstick, especially during anaerobic activities like weightlifting or sprinting. Some studies suggest accuracy remains acceptable during moderate aerobic exercise, but the risk of compression artifacts (see below) increases during floor-based activities.

Hydration and Dehydration

Because the sensor measures glucose in interstitial fluid, any change in that fluid’s composition can affect accuracy. Dehydration reduces interstitial fluid volume, concentrating glucose and potentially leading to overestimates of actual blood sugar levels. Conversely, overhydration may dilute the fluid. Users should maintain adequate fluid intake, particularly in hot weather or during exercise. If a user is severely dehydrated due to illness (e.g., vomiting, diarrhea), the sensor readings may become unreliable, and frequent fingerstick checks are recommended until hydration is restored.

Sensor Placement and Insertion Site

The Dexcom G6 should be inserted into subcutaneous tissue on the abdomen, upper buttocks, or the back of the upper arm (ages 6 and older). Placement over muscle, scar tissue, or areas that are constantly compressed (e.g., under a seatbelt or waistband) can lead to reading errors. Rotation of insertion sites is critical: reusing the same area can cause lipohypertrophy or fibrosis, both of which impair glucose diffusion into interstitial fluid and degrade accuracy. Clean the skin thoroughly with alcohol and allow it to dry before insertion to ensure proper adhesion and minimize infection risk. Using an over-patch (such as those from Skin Grip or Simpatch) can help keep the sensor stable, especially during sleep or exercise.

Sensor Lifetime and Biofouling

The Dexcom G6 is approved for up to 10 days of wear. Over this period, the sensor's accuracy typically improves in the first 24–48 hours after insertion (a "warm-up" period) and then remains stable. Toward the end of the 10-day window, accuracy may gradually decline due to biofouling—the accumulation of proteins and cells on the sensor’s electrode, which reduces sensitivity. Some users extend wear time unofficially, but this is not supported by the manufacturer and increases the risk of infection and inaccurate readings. If the sensor reports error messages or its readings become erratic after day 8, consider replacing it early.

Compression Artifacts (Pressure on the Sensor)

A common phenomenon among CGM users is the "compression low": when the sensor is pressed against a firm surface (e.g., during sleep while lying on the sensor side), pressure reduces local blood flow, leading to a dramatic drop in interstitial glucose readings even though blood glucose remains stable. Compression artifacts can also cause artificially high readings if the pressure distorts the tissue-sensor interface. To minimize this, choose a sensor location that is not directly under a hip bone or rib, and avoid sleeping on the side where the sensor is placed. If a sudden, unexplained low reading occurs during the night, change position and recheck the sensor after 10–15 minutes before treating a potential hypoglycemic event.

Medications and Interfering Substances

Certain medications can interfere with the accuracy of enzyme-based glucose sensors like the Dexcom G6. The most well-documented interferent is acetaminophen (paracetamol), which at therapeutic doses can cause artificially elevated readings. The Dexcom G6 labeling warns that doses larger than 1,000 mg every 6 hours may affect accuracy. Other substances that may interfere include ascorbic acid (vitamin C), salicylic acid (high doses), and some antibiotics. Hydroxyurea, used for sickle cell disease or certain cancers, has also been shown to cause false high readings. Users should review the complete list of potential interferents in the Dexcom G6 user guide and discuss any medications with their healthcare provider. When taking a known interfering medication, rely on fingerstick blood glucose checks for critical decisions.

Altitude and Atmospheric Pressure

Changes in atmospheric pressure can affect the diffusion of glucose through interstitial fluid and the sensor’s oxygen-dependent enzymatic reaction. While the Dexcom G6 is approved for use during air travel (up to 10,000 feet cabin altitude), some users report transient inaccuracies during ascent and descent, especially in unpressurized aircraft. High-altitude sports (e.g., mountain climbing above 14,000 feet) may also stress the sensor’s performance. Data from limited studies suggest that the G6 maintains reasonable accuracy up to moderate altitudes, but extreme changes may require more frequent calibration checks. Travelers should always carry a backup blood glucose meter.

Electromagnetic Interference

Like many wireless medical devices, the Dexcom G6 transmitter communicates via a low-power radiofrequency (RF) signal. Strong electromagnetic fields from medical imaging equipment (MRI, CT, fluoroscopy) can disrupt the transmitter’s electronics or cause the sensor to stop working altogether. The Dexcom G6 is not MRI-compatible; the sensor and transmitter must be removed before any MRI scan. Similarly, proximity to high-powered radio transmitters, industrial welding equipment, or unshielded motors can cause temporary signal loss or corrupted data. The user guide recommends keeping the receiver or smartphone at least 10 inches (25 cm) from the sensor/transmitter to ensure reliable communication.

Clinical Accuracy and MARD: What the Data Says

MARD of Dexcom G6 in Published Studies

Accuracy of CGM sensors is most commonly reported as the Mean Absolute Relative Difference (MARD) compared to a reference blood glucose measurement (often a laboratory analyzer like the YSI). A lower MARD indicates better accuracy. In pivotal clinical trials, the Dexcom G6 achieved an overall MARD of 9.9% in adults using the sensor on the abdomen, with separate studies showing similar results for arm placement (approximately 9.1% in adolescents). For comparison, the previous generation Dexcom G5 had a MARD of around 9%. The G6’s factory calibration algorithm, which eliminates the need for routine fingersticks, relies on initial sensor–transmitter matching and an internal recalibration process. Clinical performance remains stable over the 10-day wear period, with MARD maintaining <10% across days 2–10.

How the Dexcom G6 Compares to Other CGMs and Fingersticks

Fingerstick blood glucose meters typically have a MARD of 5–15% depending on the model and technique. A well-maintained meter can achieve MARD <8%, but real-world performance often exceeds 10%. The Dexcom G6’s MARD of ~9–10% places it among the most accurate factory-calibrated sensors available, comparable to Abbott’s FreeStyle Libre 2 (MARD ~9.2–9.7%) and the Medtronic Guardian 4 (MARD ~9.1% in children). However, it is important to note that CGM sensors measure interstitial fluid glucose, which lags behind blood glucose by 5–10 minutes. During periods of rapid change (e.g., after a meal or during exercise), the MARD can increase to 12–15% temporarily. Users should be aware of this lag when making treatment decisions and use trend arrows rather than absolute numbers for rapid corrections.

Best Practices to Maximize Accuracy

  • Follow insertion instructions precisely: Clean the insertion site with alcohol, allow it to dry fully, and avoid areas with excessive hair, scars, or stretch marks.
  • Use the designated body locations: The abdomen, upper buttocks, and back of the upper arm (for age 6+) are validated. Placement on thighs or other areas is not approved and may degrade accuracy.
  • Keep the sensor within its operational temperature range: Protect it from direct sunshine, cold draft, and extreme heat. Consider a waterproof shield for swimming.
  • Replace the sensor after 10 days or sooner if adhesive fails or error codes appear. Pushing beyond the approved wear time increases both infection risk and inaccuracy.
  • Avoid sleeping on the sensor: If you must sleep on the same side, place the sensor on the opposite side of the body or use a sleep position reminder device.
  • Stay hydrated: Aim for at least 8 glasses of water per day, more during physical activity or in hot climates.
  • Be cautious with medications: Check the Dexcom G6 User Guide for a list of known interferents. When taking any new medication, verify with fingersticks until the impact is clear.
  • Use trend arrows wisely: The direction of change is often more clinically actionable than a single absolute number. A flat arrow suggests stable accuracy; a 45° up arrow indicates moderate rise and may warrant a confirmatory fingerstick.
  • Update your transmitter and sensor software: Firmware updates from Dexcom often include algorithm improvements that enhance accuracy.
  • Perform a fingerstick if the sensor reading doesn’t match your symptoms: This is the golden rule: trust but verify. The FDA recommends that therapeutic decisions should be based on fingerstick measurements if there is any doubt.

When to Double-Check with a Fingerstick

Despite its high accuracy, the Dexcom G6 is not infallible. The manufacturer and most diabetes organizations advise confirming with a traditional blood glucose meter in the following scenarios:

  • When the sensor reading is below 55 mg/dL or above 350 mg/dL (edge-of-range values are less reliable).
  • When symptoms of hypoglycemia or hyperglycemia are present but the sensor shows a normal value.
  • When the sensor displays error messages (e.g., "Sensor Error" or "No Signal") and the user needs immediate data.
  • During the first 2 hours after sensor insertion (the warm-up period).
  • When taking medications known to interfere with CGM accuracy.
  • When the user is critically ill, dehydrated, or has severe edema—both interstitial and blood glucose measurements may diverge.

It is also wise to double-check before making a corrective insulin dose for a high reading if there is any suspicion of a compression artifact, sensor failure, or user error (e.g., expired transmitter battery).

The Role of Calibration

Unlike earlier CGM systems that required multiple daily fingersticks for calibration, the Dexcom G6 is a factory-calibrated sensor. This means the sensor is calibrated during manufacturing and does not require user-initiated calibrations under normal circumstances. However, if the sensor loses connection or the user experiences unexplained discrepancies, the system allows for entering up to two fingerstick calibrations per sensor session. These calibrations can improve accuracy when the sensor is far off (MARD >15%). Some users find that a single calibration on day 2 helps, particularly after a stressful insertion or if the sensor was stored outside recommended conditions. Always enter calibration values when blood glucose is stable (not rising or falling rapidly) to avoid introducing error.

Conclusion

The Dexcom G6 remains a highly accurate and life-changing tool for millions of people with diabetes. Its performance is robust across a wide range of daily activities, but it is not immune to the physical and environmental challenges that all CGMs face. By understanding the factors that influence its accuracy—temperature, exercise, hydration, placement, pressure, interference, and altitude—users can take proactive steps to ensure their data is reliable. Employing best practices and knowing when to verify with a fingerstick empowers individuals to make confident treatment decisions and maintain better glycemic control. As with any medical technology, the key to success lies in combining the device’s strengths with a healthy dose of situational awareness and common sense.

For further reading, consult the Dexcom G6 official website, FDA summary of safety and effectiveness, and a 2019 study on G6 accuracy published in the Journal of Diabetes Science and Technology.